Suppr超能文献

即刻背阔肌皮瓣乳房再造及辅助治疗后患者报告结局与关键临床结局的整合。

Integration of patient-reported outcome measures with key clinical outcomes after immediate latissimus dorsi breast reconstruction and adjuvant treatment.

机构信息

Breast Reconstruction Quality of Life and Clinical Outcomes Research Group, School of Clinical Sciences, University of Bristol and University Hospitals of Bristol NHS Foundation Trust, Bristol Royal Infirmary, Bristol, UK.

出版信息

Br J Surg. 2013 Jan;100(2):240-51. doi: 10.1002/bjs.8959. Epub 2012 Nov 22.

Abstract

BACKGROUND

Clinical evidence on patient-reported outcome measures (PROMS) in breast reconstruction is lacking. The aim of this study was to evaluate PROMs in implant-assisted latissimus dorsi (LDI) or tissue-only autologous latissimus dorsi (ALD) flap reconstruction in relation to complications and adjuvant treatments.

METHODS

This was a prospective cohort study involving six UK centres. Eligible patients had primary early-stage breast cancer. The European Organization for Research and Treatment of Cancer quality-of-life questionnaire (QLQ)-C30 and QLQ-BR23, Functional Assessment of Cancer Therapy-Breast Cancer scale (FACT-B), Body Image Scale, and Hospital Anxiety and Depression Scale were completed before operation and at 3, 6 and 12 months after surgery.

RESULTS

A total of 182 patients (82 LDI and 100 ALD) were recruited between 2007 and 2010 with symptomatic (59·9 per cent) or screen-detected (39·6 per cent) cancers. Some 64·3 per cent had lymph node-negative disease; 30 per cent of the LDI group had radiotherapy, compared with 53·0 per cent in the ALD group (P = 0·004). Early complications up to 3 months after surgery were reported in 66 and 51·0 per cent of patients in the LDI and ALD groups respectively (P = 0·062) and long-term complications (4-12 months) in 48 and 45·0 per cent (P = 0·845). Role functioning and pain (P = 0·002 for both) were adversely affected in the ALD group compared with results in the LDI group, with no significant effects of radiotherapy on any health-related quality of life (HRQL). Chemotherapy and early complications adversely affected HRQL, which improved between 3 and 12 months after surgery (P < 0·010 for all).

CONCLUSION

There is evidence of similar HRQL between types of latissimus dorsi breast reconstruction for up to a year after surgery. There appear to be no overarching effects for radiotherapy after mastectomy on the specific HRQL domains studied in the short term. The identification of variables that affect HRQL is important, including their integration into the analysis of PROMs.

摘要

背景

在乳房重建中,患者报告的结局测量(PROM)的临床证据不足。本研究旨在评估在接受辅助治疗的情况下,假体辅助背阔肌(LDI)或单纯组织自体背阔肌(ALD)皮瓣重建的 PROM,以评估与并发症的关系。

方法

这是一项涉及六个英国中心的前瞻性队列研究。纳入的患者患有原发性早期乳腺癌。在手术前和手术后 3、6 和 12 个月,使用欧洲癌症研究与治疗组织生活质量问卷(QLQ)-C30 和 QLQ-BR23、癌症治疗功能评估-乳腺癌量表(FACT-B)、身体意象量表和医院焦虑抑郁量表进行评估。

结果

2007 年至 2010 年间,共招募了 182 名患者(82 名 LDI 和 100 名 ALD),其中 59.9%为症状性癌症,39.6%为筛查性癌症。64.3%的患者无淋巴结转移;LDI 组 30%的患者接受了放疗,而 ALD 组 53.0%的患者接受了放疗(P=0.004)。术后 3 个月内,LDI 和 ALD 组分别有 66%和 51.0%的患者出现早期并发症(P=0.062),4-12 个月时出现长期并发症(48%和 45.0%)(P=0.845)。与 LDI 组相比,ALD 组角色功能和疼痛(均为 P=0.002)受到不利影响,放疗对任何健康相关生活质量(HRQL)均无显著影响。化疗和早期并发症对 HRQL 产生不利影响,术后 3-12 个月后 HRQL 有所改善(所有 P<0.010)。

结论

在术后一年,背阔肌重建的两种类型在 HRQL 方面均有相似的结果。在短期内,乳房切除术后放疗对所研究的特定 HRQL 领域似乎没有总体影响。确定影响 HRQL 的变量很重要,包括将其纳入 PROM 的分析中。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验